首页> 美国卫生研究院文献>Arthritis Research >Interleukin-17A promotes functional activation of systemic sclerosis patient-derived dermal vascular smooth muscle cells by extracellular-regulated protein kinases signalling pathway
【2h】

Interleukin-17A promotes functional activation of systemic sclerosis patient-derived dermal vascular smooth muscle cells by extracellular-regulated protein kinases signalling pathway

机译:白细胞介素17A通过细胞外调节蛋白激酶信号通路促进系统性硬化症患者源性真皮血管平滑肌细胞的功能激活

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

IntroductionDermal vascular smooth muscle cells (DVSMCs) are important for vascular wall fibrosis in microangiopathy of systemic sclerosis (SSc). T helper 17 cell-associated cytokines, particularly interleukin-17A (IL-17A), have been demonstrated to play a role in the pathogenesis of SSc. However, the effect of IL-17A on the DVSMCs in microangiopathy of SSc has not been established. In the present study, we investigated the effect of IL-17A on the SSc patient-derived DVSMCs.
机译:简介皮肤血管平滑肌细胞(DVSMC)对于系统性硬化症(SSc)的微血管病中的血管壁纤维化很重要。 T辅助细胞17细胞相关的细胞因子,特别是白介素17A(IL-17A),已被证明在SSc的发病机理中起作用。然而,尚未确定IL-17A对SSc微血管病中DVSMC的作用。在本研究中,我们调查了IL-17A对SSc患者来源的DVSMC的影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号